Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Change of Auditor
Induction (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces that following a competitive and comprehensive tender process, Crowe U.K. LLP will be appointed as the Company's auditor for the year ending 31 March 2023. The Company intends to put the appointment of Crowe U.K. LLP as auditor to a vote of shareholders at the Company's next Annual General Meeting.
KPMG LLP, the Company's current auditor, will cease to hold office as the Group's auditor when the present term of office expires at the conclusion of the Company's 2023 AGM. KPMG LLP has confirmed that there are no matters connected with it ceasing to hold office that should be brought to the attention of the members or creditors of the Company.
ENQUIRIES
| Induction James Balmain, Chief Executive Officer Christopher Samler, Non-Executive Chair | Via Walbrook PR Ltd: induction@walbrookpr.com |
| | |
| Singer Capital Markets (Nominated Adviser and Broker) | +44 (0)20 7496 3000 |
| Philip Davies / Kailey Aliyar | |
| | |
| Walbrook PR Ltd | induction@walbrookpr.com |
| Alice Woodings / Paul McManus | Mob: +44 (0)7407 804 654 / +44(0)7980 541 893 |
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
